A communication was established between the left subclavian artery and left atrium in dogs to assess the acute dynamic effects of a diastolic input load on the left heart. Sudden diastolic pressure loading, produced by opening the shunt abruptly was followed by acute ventricular dilatation and fibrillation, and pulmonary congestion and edema. Gradual opening of the shunt provided time for cardiac adjustments to the increased ventricular output, and acute failure did not occur. These data suggest that adjustments in myocardial function can take place quickly in response to a markedly enhanced input load. On opening the shunt the aortic pressure fell in consonance with the decreased total peripheral resistance, while the left atrial pressure increased sharply. The pulmonary arterial pressure remained unchanged. Systemic vasoconstriction produced by adrenalin, strophanthin or asphyxia enhanced the flow through the shunt.
It is the purpose of this presentation to add a seven-year experience to the evergrowing literature of the treatment of hyperthyroidism with radioactive iodine. This experience with 294 consecutive patients has led to the formation of some opinions concerning several controversial aspects, such as minimum age for treatment, size of dose and dosage schedules, and effects of supplementary antithyroid drugs. Material and MethodsA total of 294 patients (237 females and 57 males) with hyperthyroidism, from the Radioisotope Service of the Jewish Memorial Hospital, New York, and from our private files over the past seven years constitute the basis of this report. The diagnosis of hyperthyroidism was established by a complete history, physical examination, and an I131 thyroid profile.1 The thyroid profile consists of a 24-hour uptake, conversion ratio, and measurement of the radioactivity of the saliva. In many instances a basal metabolic rate, chemical protein-bound iodine, and serum cholesterol determinations were included. All patients were seen within six to eight weeks after the oral administration of I181, or earlier if any untoward symptoms developed. The initial follow-up consisted of clinical and laboratory evaluation. The former included the patient's symp¬ toms and a careful record of weight, pulse rate, blood pressure, grading of tremors, moisture of palms, state of the eyes, and the size and char¬ acter of the thyroid gland. The size of the thyroid gland was estimated by palpation and recorded in grams, the accepted normal being 25 gm. Hertel exophthalmometer measurements were performed whenever exophthalmos was noted or suspected. Laboratory tests included the 24-hour I1"1 uptake and measurement of salivary radioactivity. The conversion ratio was omitted because of its recog¬ nized invalidity after Im therapy.1 Patients were followed every two months during the first year, and if remission persisted, the intervals were in¬ creased to six months and then to one year. In the entire series, 55 patients were observed for less than one year, 130 from one to two years, 33 for three years, 28 for four years, 24 for five years, 12 for six years, and 10 for seven years.The dosages * in this study were expressed in rept (roentgen equivalents physical), the com¬ monly employed unit of absorbed radiation. A dosage schedule was established empirically, de¬ pendent upon three factors : the patient's age, the degree of clinical toxicity, and the character of the gland. Three arbitrary age groups were es¬ tablished, each of which was given an estimated dosage range as follows: up to 40 (young), 3,000-9,000 rep; 40-60 (middle), 6,000-12,000 rep; above 60 (old), 9,000-15,000 rep. The dosage within each age range was modified by the degree of clinical toxicity; the more toxic patient received a smaller dosage. Similarly, patients with diffuse, soft glands were treated with lower dosages than those with nodular glands. As an example, a moderately toxic patient with a diffuse soft gland in the middle age group was given a dosag...
No abstract
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.